SurGenTec, a minimally invasive orthobiologics company, has announced that the United States Patent and Trademark Office (USPTO) has granted a new patent for its bone graft delivery technology.
The proprietary Graftgun delivery system is designed to enable surgeons to deliver the bone graft of their choice (synthetic, allograft, or autograft) in a minimally invasive fashion.
Traditionally, surgeons have used a metal funnel and tamp to place bone graft. SurGenTec, according to a press release, intends to overcome the difficulties and dangers with this technique. The product is designed to provide a simple, safe and ergonomic solution to deliver bone graft in hard-to-reach places.
The Graftgun kit includes a loading device and multiple tube sizes to support a variety of surgical procedures and patient sizes. The tubes have embedded radiopaque markers to enable the surgeon the fluoroscopic visualisation of bone graft placement. Ratcheting technology is designed to provide the force necessary to extrude the majority of bone grafts on the market.
The patent adds to SurGenTec’s portfolio of existing patents and patents pending.
The press release states that SurGenTec also has several further up-and-coming technologies that will be rolled out over the course of this year.
